T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients

Bone Marrow Transplantation
Richard K BurtW Burns

Abstract

Multiple sclerosis (MS) is a disease of the central nervous system characterized by immune-mediated destruction of myelin. In patients with progressive deterioration, we have intensified immunosuppression to the point of myeloablation. Subsequently, a new hematopoietic and immune system is generated by infusion of CD34-positive hematopoietic stem cells (HSC). Three patients with clinical MS and a decline of their Kurtzke extended disability status scale (EDSS) by 1.5 points over the 12 months preceding enrollment and a Kurtzke EDSS of 8.0 at the time of enrollment were treated with hematopoietic stem cell (HSC) transplantation using a myeloablative conditioning regimen of cyclophosphamide (120 mg/kg), methylprednisolone (4 g) and total body irradiation (1200 cGy). Reconstitution of hematopoiesis was achieved with CD34-enriched stem cells. The average time of follow-up is 8 months (range 6-10 months). Despite withdrawal of all immunosuppressive medications, functional improvements have occurred in all three patients. We conclude that T cell-depleted hematopoietic stem cell transplantation can be performed safely in patients with severe and debilitating multiple sclerosis. Stem cell transplantation has resulted in modest neurolog...Continue Reading

Citations

Nov 15, 2002·International Journal of Hematology·Richard K BurtAlberto M Marmont
Nov 19, 2004·Springer Seminars in Immunopathology·Richard K BurtShimon Slavin
Jul 18, 2001·Springer Seminars in Immunopathology·J Moore, P Brooks
Nov 30, 2000·Current Treatment Options in Neurology·B Bielekova, R Martin
Oct 15, 2003·Blood Reviews·Athanasios Fassas, Vassilios K Kimiskidis
Aug 10, 1999·Critical Reviews in Oncology/hematology·A Gratwohl, A Tyndall
Jun 10, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kc BijuSenlin Li
Mar 28, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christopher B DoeringH Trent Spencer
Aug 31, 2002·Journal of Hematotherapy & Stem Cell Research·Jeffrey GrynJane M Raymond
Apr 3, 1999·Current Opinion in Oncology·R A Brodsky, B D Smith
Nov 5, 2005·Acta Haematologica·Alan Tyndall, Thomas Daikeler
Aug 5, 2008·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Dragana ObradovićVladimir Kostić
Jun 26, 2010·Expert Review of Hematology·Christopher B Doering, H Trent Spencer
Oct 2, 2003·Expert Opinion on Biological Therapy·Alan Tyndall, Marco Matucci-Cerinic
Dec 17, 2014·Clinical and Experimental Medicine·Angelo De CataGianluigi Mazzoccoli
Aug 26, 2004·British Journal of Haematology·Uday Popat, Robert Krance
Feb 3, 2005·British Journal of Haematology·R E HoughN M Wulffraat
Feb 13, 2010·The Australasian Journal of Dermatology·Pablo F Peñas, Sarah Zaman
Aug 11, 2004·Best Practice & Research. Clinical Haematology·Athanasios Fassas, Richard Nash
Jul 21, 2004·Journal of the Neurological Sciences·Athanasios Fassas, Vasilios K Kimiskidis
Apr 18, 2000·Rheumatic Diseases Clinics of North America·R A BrodskyR J Jones
Sep 1, 2015·Methods : a Companion to Methods in Enzymology·Christopher D PoradaGraça Almeida-Porada
Jun 19, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcelo C PasquiniRichard A Nash
Apr 2, 2002·Best Practice & Research. Clinical Haematology·A GratwohlUNKNOWN International Stem Cell Project for Autoimmune Diseases
Mar 15, 2005·Cytotherapy·P A MuraroR Martin
Oct 3, 1998·Clinical Immunology and Immunopathology·D W van Bekkum
Oct 2, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·A ReiffK Weinberg
Dec 5, 2002·Neurorehabilitation and Neural Repair·Jack S BurksKottil W Rammohan
Jul 12, 2007·Multiple Sclerosis : Clinical and Laboratory Research·D R Jeffery
Feb 1, 2007·Multiple Sclerosis : Clinical and Laboratory Research·R SaccardiUNKNOWN Autoimmune Diseases Working Party of EBMT
Apr 15, 2003·Bone Marrow Transplantation·R K BurtA M Marmont
Aug 22, 2003·Bone Marrow Transplantation·R K Burt, T Kozak
Mar 21, 2000·Bone Marrow Transplantation·E Jantunen, R Myllykangas-Luosujärvi
Aug 11, 2001·Bone Marrow Transplantation·R K BurtP A McSweeney
Oct 9, 2002·Oncogene·Jian-Ping YangFlossie Wong-Staal
Apr 13, 2007·American Journal of Physiology. Renal Physiology·Alexander W KrugStefan Silbernagl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.